| Authors: |
Bonaud A; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France., Gargowitsch L; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France., Gilbert SM; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK., Rajan E; School of Bioscience, University of Sheffield, Sheffield S102TN, UK., Canales-Herrerias P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France., Stockholm D; PSL Research University, EPHE, 75014 Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France., Rahman NF; Dementia Research Institute, University of Cardiff, Cardiff CF24 4HQ, UK., Collins MO; School of Bioscience, University of Sheffield, Sheffield S102TN, UK., Taskiran H; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich 81675, Germany.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg im Breisgau, Germany., Hill DL; Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Immunology and Pathology, Monash University, Melbourne, VIC 3004, Australia., Alloatti A; PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.; Facultad de Ciencias Médicas, Instituto de Inmunología Clínica y Experimental de Rosario (IDICER)-CONICET/Universidad Nacional de Rosario, S2002LRL Rosario, Argentina., Alouche N; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France., Balor S; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France., Soldan V; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France., Gillet D; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France., Barbier J; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France., Bachelerie F; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France., Smith KGC; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical, University of Cambridge, Cambridge CB2 0AW, UK., Jellusova J; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich 81675, Germany., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France., Amigorena S; PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France., Balabanian K; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France., Linterman MA; Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK., Peden AA; School of Bioscience, University of Sheffield, Sheffield S102TN, UK., Espéli M; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France. |
